• Mashup Score: 10
    Hematopoietic Cell Transplantation and Cell therapy weekly newsletter - Issue #21 - 2 year(s) ago

    OUT THiS WEEK!CRISPR anti CD19 #CARTS @natureMDR after #ASCT in #myeloma @JCO_ASCOATRA & BCMA expression @haematologicaTISACEL + pembro @BloodAdvances

    Source: www.getrevue.co
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Eddie_Cliff
      Eddie_Cliff

      RT @albertomussetti: Hematopoietic Cell Transplantation and Cell therapy weekly newsletter - Issue #21 https://t.co/BB15VbQlrg OUT THiS WE…

    • Profile photo of albertomussetti
      albertomussetti

      Hematopoietic Cell Transplantation and Cell therapy weekly newsletter - Issue #21 https://t.co/BB15VbQlrg OUT THiS WEEK! CRISPR anti CD19 #CARTS @nature MDR after #ASCT in #myeloma @JCO_ASCO ATRA & BCMA expression @haematologica TISACEL + pembro @BloodAdvances

    • Profile photo of JCO_ASCO
      JCO_ASCO

      RT @albertomussetti: Hematopoietic Cell Transplantation and Cell therapy weekly newsletter - Issue #21 https://t.co/BB15VbQlrg OUT THiS WE…

  • Mashup Score: 0
    7th International Transplant Course - 2 year(s) ago

    Dear Colleagues, It is our great pleasure to welcome you on behalf of our society to the 7th International Transplant Course 2-4 September 2022. I am so excited and relieved to announce to you that this year we are back to ‘normal’ with a regular face-to-face meeting in the heart of Barcelona!  We have worked hard to provide a broad, up-to-date and concise overview of all relevant topics in…

    Source: EBMT
    Categories: Hematologists1, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of albertomussetti
      albertomussetti

      Happy to be back to a face-to-face meeting with the @TheEBMT 2022 International #Transplant #Course in Barcelona @HHospitalet @ICO_oncologia See you for the "#CARTs in #lymphoma" discussion! Check the program! https://t.co/dUTOIRNlUs

  • Mashup Score: 4
    Program Guide – ASCO Meeting Program Guide - 2 year(s) ago

    AuthorsMichael DickinsonPeter MacCallum Cancer Centre, Royal Melbourne Hospital and The University of Melbourne, Melbourne, AustraliaMichael Dickinson, Carmelo Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Tomasz Wrobel, Fritz Offner, Marek Trneny, Shang-Ju Wu, Guillaume Cartron, Mark Hertzberg, Anna Sureda Balari, David Perez-Callejo, Linda…

    Source: meetings.asco.org
    Categories: Hematologists1, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HayderSaeed_MD
      HayderSaeed_MD

      #Glofitamab showing good results in a difficult DLBCL #lymsm population with many post #CARTs, ORR 50% with CR of 35% #ASCO22 https://t.co/gmmu34AKFi

  • Mashup Score: 1
    Program Guide – ASCO Meeting Program Guide - 2 year(s) ago

    AuthorsFrederick L. LockeH. Lee Moffitt Cancer Center & Research Institute, Tampa, FLFrederick L. Locke, Tanya Siddiqi, Caron Alyce Jacobson, Armin Ghobadi, Sairah Ahmed, David Bernard Miklos, Miguel-Angel Perales, Javier Munoz, Brent Logan, Zhen-Huan Hu, Harry H. Miao, Kanwarjit Singh, Jina Shah, Hairong Xu, Marcelo C. PasquiniOrganizationsH. Lee Moffitt Cancer Center & Research Institute,…

    Source: meetings.asco.org
    Categories: Hematologists1, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HayderSaeed_MD
      HayderSaeed_MD

      ⁦@DrFredLocke⁩ ⁦@MoffittNews⁩ presenting on the race disparity in #CARTs real life evidence #lymsm #ASCO22, interesting findings for lowed responses seen in African Americans https://t.co/yKxA7oxYpr

  • Mashup Score: 5
    Ide-cel: EC approval and updated results from KarMMa - 3 year(s) ago

    In March 2021, idecabtagene vicleucel (ide-cel) became the first B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor (CAR) T-cell therapy to be approved for the treatment of adults with relapsed/refractory (R/R) multiple myeloma (MM).

    Source: multiplemyelomahub.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of MM_Hub
      MM_Hub

      CONGRESS | #IACH2021 | Reviewing the data of #CARTs in #myeloma, @Mohty_EBMT points out the OS numbers reported in the KarMMA trial, which could mean these pts can be salvaged after CAR-T cell therapy. @TheIACH #mmsm https://t.co/5CAbD2IuMz